Annual Retained Earnings
-$544.30 M
-$200.07 M-58.12%
31 December 2023
Summary:
Verve Therapeutics annual retained earnings is currently -$544.30 million, with the most recent change of -$200.07 million (-58.12%) on 31 December 2023. During the last 3 years, it has fallen by -$477.77 million (-718.06%). VERV annual retained earnings is now -2512.83% below its all-time high of -$20.83 million, reached on 31 December 2019.VERV Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$692.98 M
-$50.13 M-7.80%
30 September 2024
Summary:
Verve Therapeutics quarterly retained earnings is currently -$692.98 million, with the most recent change of -$50.13 million (-7.80%) on 30 September 2024. Over the past year, it has dropped by -$197.03 million (-39.73%). VERV quarterly retained earnings is now -941.51% below its all-time high of -$66.54 million, reached on 01 December 2020.VERV Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.1% | -39.7% |
| 3 y3 years | -718.1% | -345.6% |
| 5 y5 years | - | - |
VERV Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -718.1% | at low | -345.6% | at low |
| 5 y | 5 years | -2512.8% | at low | -941.5% | at low |
| alltime | all time | -2512.8% | at low | -941.5% | at low |
Verve Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$692.98 M(+7.8%) |
| June 2024 | - | -$642.85 M(+8.4%) |
| Mar 2024 | - | -$593.04 M(+9.0%) |
| Dec 2023 | -$544.30 M(+58.1%) | -$544.30 M(+9.7%) |
| Sept 2023 | - | -$495.95 M(+10.2%) |
| June 2023 | - | -$450.19 M(+13.6%) |
| Mar 2023 | - | -$396.21 M(+15.1%) |
| Dec 2022 | -$344.24 M | -$344.24 M(+13.6%) |
| Sept 2022 | - | -$303.15 M(+17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | -$257.96 M(+18.9%) |
| Mar 2022 | - | -$217.02 M(+16.1%) |
| Dec 2021 | -$186.85 M(+180.8%) | -$186.85 M(+20.2%) |
| Sept 2021 | - | -$155.51 M(+17.1%) |
| June 2021 | - | -$132.76 M(+66.4%) |
| Mar 2021 | - | -$79.80 M(+19.9%) |
| Dec 2020 | -$66.54 M(+219.4%) | - |
| Dec 2020 | - | -$66.54 M |
| Dec 2019 | -$20.83 M | - |
FAQ
- What is Verve Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Verve Therapeutics?
- What is Verve Therapeutics annual retained earnings year-on-year change?
- What is Verve Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Verve Therapeutics?
- What is Verve Therapeutics quarterly retained earnings year-on-year change?
What is Verve Therapeutics annual retained earnings?
The current annual retained earnings of VERV is -$544.30 M
What is the all time high annual retained earnings for Verve Therapeutics?
Verve Therapeutics all-time high annual retained earnings is -$20.83 M
What is Verve Therapeutics annual retained earnings year-on-year change?
Over the past year, VERV annual retained earnings has changed by -$200.07 M (-58.12%)
What is Verve Therapeutics quarterly retained earnings?
The current quarterly retained earnings of VERV is -$692.98 M
What is the all time high quarterly retained earnings for Verve Therapeutics?
Verve Therapeutics all-time high quarterly retained earnings is -$66.54 M
What is Verve Therapeutics quarterly retained earnings year-on-year change?
Over the past year, VERV quarterly retained earnings has changed by -$197.03 M (-39.73%)